Evolutionary conservation analysis increases the colocalization of predicted exonic splicing enhancers in the BRCA1 gene with missense sequence changes and in-frame deletions, but not polymorphisms

被引:23
作者
Pettigrew, C
Wayte, N
Lovelock, PK
Tavtigian, SV
Chenevix-Trench, G
Spurdle, AB
Brown, MA [1 ]
机构
[1] Univ Queensland, Sch Mol & Microbial Sci, St Lucia, Qld, Australia
[2] Queensland Inst Med Res, Herston, Qld 4006, Australia
[3] Int Agcy Res Canc, F-69372 Lyon, France
来源
BREAST CANCER RESEARCH | 2005年 / 7卷 / 06期
基金
英国医学研究理事会;
关键词
D O I
10.1186/bcr1324
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction Aberrant pre-mRNA splicing can be more detrimental to the function of a gene than changes in the length or nature of the encoded amino acid sequence. Although predicting the effects of changes in consensus 5' and 3' splice sites near intron: exon boundaries is relatively straightforward, predicting the possible effects of changes in exonic splicing enhancers (ESEs) remains a challenge. Methods As an initial step toward determining which ESEs predicted by the web-based tool ESEfinder in the breast cancer susceptibility gene BRCA1 are likely to be functional, we have determined their evolutionary conservation and compared their location with known BRCA1 sequence variants. Results Using the default settings of ESEfinder, we initially detected 669 potential ESEs in the coding region of the BRCA1 gene. Increasing the threshold score reduced the total number to 464, while taking into consideration the proximity to splice donor and acceptor sites reduced the number to 211. Approximately 11% of these ESEs (23/211) either are identical at the nucleotide level in human, primates, mouse, cow, dog and opossum Brca1 ( conserved) or are detectable by ESEfinder in the same position in the Brca1 sequence ( shared). The frequency of conserved and shared predicted ESEs between human and mouse is higher in BRCA1 exons (2.8 per 100 nucleotides) than in introns (0.6 per 100 nucleotides). Of conserved or shared putative ESEs, 61% (14/23) were predicted to be affected by sequence variants reported in the Breast Cancer Information Core database. Applying the filters described above increased the colocalization of predicted ESEs with missense changes, in-frame deletions and unclassified variants predicted to be deleterious to protein function, whereas they decreased the colocalization with known polymorphisms or unclassified variants predicted to be neutral. Conclusion In this report we show that evolutionary conservation analysis may be used to improve the specificity of an ESE prediction tool. This is the first report on the prediction of the frequency and distribution of ESEs in the BRCA1 gene, and it is the first reported attempt to predict which ESEs are most likely to be functional and therefore which sequence variants in ESEs are most likely to be pathogenic.
引用
收藏
页码:R929 / R939
页数:11
相关论文
共 54 条
[1]   Mechanisms of alternative pre-messenger RNA splicing [J].
Black, DL .
ANNUAL REVIEW OF BIOCHEMISTRY, 2003, 72 :291-336
[2]   Structure of a BRCA1-BARD1 heterodimeric RING-RING complex [J].
Brzovic, PS ;
Rajagopal, P ;
Hoyt, DW ;
King, MC ;
Klevit, RE .
NATURE STRUCTURAL BIOLOGY, 2001, 8 (10) :833-837
[3]   Listening to silence and understanding nonsense: Exonic mutations that affect splicing [J].
Cartegni, L ;
Chew, SL ;
Krainer, AR .
NATURE REVIEWS GENETICS, 2002, 3 (04) :285-298
[4]   Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1 [J].
Cartegni, L ;
Krainer, AR .
NATURE GENETICS, 2002, 30 (04) :377-384
[5]   ESEfinder: a web resource to identify exonic splicing enhancers [J].
Cartegni, L ;
Wang, JH ;
Zhu, ZW ;
Zhang, MQ ;
Krainer, AR .
NUCLEIC ACIDS RESEARCH, 2003, 31 (13) :3568-3571
[6]  
*CHIP, CHIP BIOINF TOOLS
[7]   Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2 [J].
Claes, K ;
Poppe, B ;
Machackova, E ;
Coene, I ;
Foretova, L ;
De Paepe, A ;
Messiaen, L .
GENES CHROMOSOMES & CANCER, 2003, 37 (03) :314-320
[8]   Pathological splice mutations outside the invariant AG/GT splice sites of BRCA1 exon 5 increase alternative transcript levels in the 5′ end of the BRCA1 gene [J].
Claes, K ;
Vandesompele, J ;
Poppe, B ;
Dahan, K ;
Coene, I ;
De Paepe, A ;
Messiaen, L .
ONCOGENE, 2002, 21 (26) :4171-4175
[9]   ΔN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53 [J].
Courtois, S ;
Verhaegh, G ;
North, S ;
Luciani, MG ;
Lassus, P ;
Hibner, U ;
Oren, M ;
Hainaut, P .
ONCOGENE, 2002, 21 (44) :6722-6728
[10]  
Dobrovic A, 1997, CANCER RES, V57, P3347